Literature DB >> 22915289

The postoperative cortisol stress response following transsphenoidal pituitary surgery: a potential screening method for assessing preserved pituitary function.

Gabriel Zada1, Amir Tirosh, Abel P Huang, Edward R Laws, Whitney W Woodmansee.   

Abstract

The ability to reliably identify patients with new hypocortisolemia acutely following pituitary surgery is critical. We aimed to quantify the postoperative cortisol stress response following selective transsphenoidal adenomectomy, as a marker for postoperative preservation of functional pituitary gland. Records of 208 patients undergoing transsphenoidal operations for pituitary lesions were reviewed. Patients with Cushing's Disease, preoperative adrenal insufficiency, and those receiving intraoperative steroids were excluded. To quantify the postoperative stress response, the ∆ cortisol index was defined as the postoperative day (POD) 1 morning cortisol minus the preoperative morning cortisol level. The incidence of new hypocortisolemia requiring glucocorticoid replacement upon hospital discharge was also recorded. Fifty-two patients met inclusion criteria. The mean preoperative, POD1, and POD2 cortisol levels were 16.5, 29.2, and 21.8 μg/dL, respectively. Morning fasting cortisol levels on POD1 ranged from 4.2 to 73.0 μg/dL. The ∆ cortisol index ranged from -19.0 to +56.2 (mean +12.7 μg/dL). Five patients (9.6%) developed new hypocortisolemia on POD 1-3 requiring glucocorticoid replacement; only one required long-term replacement. The mean ∆ cortisol in patients requiring postoperative glucocorticoids was -2.8 μg/dL, compared with +14.4 μg/dL in patients without evidence of adrenal insufficiency (p = 0.005). Of the 32 patients (61.5%) with a ∆cortisol >25 μg/dL, none developed postoperative adrenal insufficiency. The postoperative cortisol stress response, as quantified by the ∆ cortisol index, holds potential as a novel and complimentary screening method to predict preservation of normal pituitary function and acute development of new ACTH deficiency following transsphenoidal pituitary surgery.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 22915289      PMCID: PMC5136529          DOI: 10.1007/s11102-012-0423-7

Source DB:  PubMed          Journal:  Pituitary        ISSN: 1386-341X            Impact factor:   4.107


  21 in total

1.  Impact of primary surgery on pituitary function in patients with non-functioning pituitary adenomas -- a study on 721 patients.

Authors:  P Nomikos; C Ladar; R Fahlbusch; M Buchfelder
Journal:  Acta Neurochir (Wien)       Date:  2004-01-07       Impact factor: 2.216

2.  Systemic stress hormone response in patients undergoing open heart surgery with or without cardiopulmonary bypass.

Authors:  M Raschid Hoda; Habib El-Achkar; Edgar Schmitz; Thomas Scheffold; Herbert O Vetter; Raffaele De Simone
Journal:  Ann Thorac Surg       Date:  2006-12       Impact factor: 4.330

3.  Evaluation of the pituitary-adrenal axis before, during and after pituitary adenomectomy. Is perioperative glucocorticoid therapy necessary?

Authors:  P P García-Luna; A Leal-Cerro; J L Rocha; F Trujillo; F Garcia-Pesquera; R Astorga
Journal:  Acta Endocrinol (Copenh)       Date:  1990-01

4.  A comparison of the insulin tolerance/glucagon test with the short ACTH stimulation test in the assessment of the hypothalamo-pituitary-adrenal axis in the early post-operative period after hypophysectomy.

Authors:  J J Mukherjee; J J de Castro; G Kaltsas; F Afshar; A B Grossman; J A Wass; G M Besser
Journal:  Clin Endocrinol (Oxf)       Date:  1997-07       Impact factor: 3.478

5.  A randomized, prospective, blinded comparison of postoperative pain, metabolic response, and perceived health after laparoscopic and small incision cholecystectomy.

Authors:  D M Squirrell; A W Majeed; G Troy; J E Peacock; J P Nicholl; A G Johnson
Journal:  Surgery       Date:  1998-05       Impact factor: 3.982

Review 6.  Hypothalamic pituitary adrenal function during critical illness: limitations of current assessment methods.

Authors:  Baha M Arafah
Journal:  J Clin Endocrinol Metab       Date:  2006-08-01       Impact factor: 5.958

7.  Cortisol response in relation to the severity of stress and illness.

Authors:  Isabelle E Widmer; Jardena J Puder; Caroline König; Hans Pargger; Hans Reinhard Zerkowski; Jürg Girard; Beat Müller
Journal:  J Clin Endocrinol Metab       Date:  2005-05-10       Impact factor: 5.958

8.  Day 5 morning serum cortisol predicts hypothalamic-pituitary-adrenal function after transsphenoidal surgery for pituitary tumors.

Authors:  Channa N Jayasena; Kunal A Gadhvi; Bhavini Gohel; Niamh M Martin; Nigel Mendoza; Karim Meeran; Waljit S Dhillo
Journal:  Clin Chem       Date:  2009-03-12       Impact factor: 8.327

Review 9.  Glucocorticoid replacement in pituitary surgery: guidelines for perioperative assessment and management.

Authors:  Warrick J Inder; Penny J Hunt
Journal:  J Clin Endocrinol Metab       Date:  2002-06       Impact factor: 5.958

10.  Use of morning serum cortisol level after transsphenoidal resection of pituitary adenoma to predict the need for long-term glucocorticoid supplementation.

Authors:  Nicholas F Marko; Vivek A Gonugunta; Amir H Hamrahian; Ali Usmani; Marc R Mayberg; Robert J Weil
Journal:  J Neurosurg       Date:  2009-09       Impact factor: 5.115

View more
  3 in total

1.  Early postoperative HPA-axis testing after pituitary tumor surgery: reliability and safety of basal cortisol and CRH test.

Authors:  Friso de Vries; Daniel J Lobatto; Leontine E H Bakker; Wouter R van Furth; Nienke R Biermasz; Alberto M Pereira
Journal:  Endocrine       Date:  2019-09-25       Impact factor: 3.633

2.  Lower-dose perioperative steroid protocol during endoscopic endonasal pituitary adenoma resection.

Authors:  Nathan C Pecoraro; Daniel M Heiferman; Brendan Martin; Daphne Li; Stephen J Johans; Chirag R Patel; Anand V Germanwala
Journal:  Surg Neurol Int       Date:  2019-04-24

3.  Outcomes of Total Hip Arthroplasty in Patients with Osteonecrosis of the Femoral Head Following Surgical Treatment of Brain Tumors.

Authors:  Seung-Jae Lim; Chan-Woo Park; Dong-Uk Kim; Kwangjoon Han; Minkyu Seo; Young-Wan Moon; Jung-Il Lee; Youn-Soo Park
Journal:  J Clin Med       Date:  2019-10-16       Impact factor: 4.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.